"These findings from a modern nationwide longitudinal cohort study suggest that obesity is a dominant feature of many health ...

According to Benzinga Pro, Amgen's peer group average for short interest as a percentage of float is 5.85%, which means the ...

Hiring Dalia Rayes as head of commercial for the global efzofitimod franchise slots another piece of the puzzle into place.

AbbVie’s Humira was the top-selling drug in the world for many years. Now, its sales are eroding as doctors switch to ...

In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Axsome Therapeutics (AXSM – Research Report), with a ...

Fresenius said the U.S. Food and Drug Administration has approved a biologics license application for its operating company's bone-disease drugs. The approval concerns Fresenius Kabi's Conexxence and ...

Total Revenues in 2024 reached $492 million, representing a 427% increase over prior yearProduct Revenues in 2024 reached $273 million, ...

Launched on 08/08/2017, the First Trust Dow 30 Equal Weight ETF (EDOW) is a passively managed exchange traded fund designed to provide a broad exposure to the Large Cap Blend segment of the US equity ...

In a decision issued today, the Federal Circuit addressed the issue of whether an Examiner can rely on the filing date of a provisional ...

The International Society for Pharmaceutical Engineering (ISPE) has announced its keynote speakers at the 2025 ISPE Biotechnology Conference, taking place Monday, 2 June, through Tuesday, 3 June, in ...

Just a few years since pioneering a Covid-19 vaccine, Moderna faces a hostile political environment and a looming patent ...

DelveInsight's "LUXTURNA Market Size, Forecast, and Market Insight Report" highlights the details around LUXTURNA, a one-time ...